OR WAIT null SECS
© 2021 MJH Life Sciences and Urology Times. All rights reserved.
© 2021 MJH Life Sciences™ and Urology Times. All rights reserved.
“Tramadol is a mixed-class medication and it has weak opioid agonist activity. Normally, we consider that a safer option compared to other opioids, but it's actually a pro drug, so it has to be metabolized to have an effect,” says Sarah F. Faris, MD.
In this video, Sarah F. Faris, MD, discusses the findings of the Urology study, “Persistent Opioid Usage After Urologic Intervention and the Impact of Tramadol,” and how tramadol can have varying impacts on patients after urologic intervention. Faris is an associate professor of surgery at the University of Chicago, Illinois.